Pyxis Oncology Ownership | Who Owns Pyxis Oncology?

Overview Forecast RevenueFinancials Chart

Pyxis Oncology Ownership Summary

Pyxis Oncology is owned by 45.93% institutional investors, 24.54% insiders, and 29.53% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 8.16% of PYXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.18% of its assets in Pyxis Oncology shares.

PYXS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pyxis Oncology	45.93%	24.54%	29.53%
Sector	Healthcare Stocks	46.80%	8.14%	45.06%
Industry	Biotech Stocks	44.70%	7.99%	47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Deep track capital, lp	4.18M	8.16%	$13.85M
Laurion capital management lp	3.86M	7.53%	$12.78M
Blackrock	2.79M	5.43%	$9.22M
Balyasny asset management	2.56M	5.00%	$8.48M
Vanguard group	2.06M	4.02%	$6.82M
Stempoint capital lp	1.20M	2.34%	$3.98M
Blue owl capital lp	1.05M	2.04%	$3.46M
Geode capital management	1.03M	2.00%	$3.40M
State street	742.91K	1.45%	$2.46M
Abrdn	708.30K	1.38%	$2.34M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Stempoint capital lp	1.20M	1.17%	$3.98M
Blue owl capital lp	1.05M	0.96%	$3.46M
Deep track capital, lp	4.18M	0.41%	$13.85M
Decheng capital	326.81K	0.33%	$1.08M
Yu fan	69.30K	0.30%	$229.39K
Cable car capital	61.61K	0.21%	$203.92K
Ikarian capital	3.59K	0.21%	$1.19M
Laurion capital management lp	3.86M	0.15%	$12.78M
University of chicago	48.73K	0.12%	$161.30K
Pier 88 investment partners	113.70K	0.08%	$376.35K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	2.79M	0.00%	2.46M
Blue owl capital lp	1.05M	0.96%	1.05M
Geode capital management	1.03M	0.00%	687.59K
Vanguard group	2.06M	0.00%	659.02K
State street	742.91K	0.00%	633.55K

Top Sellers

Holder	Shares	% Assets	Change
Stempoint capital lp	1.20M	1.17%	-591.52K
Superstring capital management lp	-	-	-484.44K
Monashee investment management	-	-	-442.50K
Goldman sachs group	117.25K	0.00%	-219.44K
Jane street group	35.21K	-	-140.04K

New Positions

Holder	Shares	% Assets	Change	Value
Blue owl capital lp	1.05M	0.96%	1.05M	$3.46M
Nuveen asset management	149.02K	0.00%	149.02K	$493.27K
Boothbay fund management	99.10K	0.01%	99.10K	$328.02K
Rhumbline advisers	65.29K	0.00%	65.29K	$216.09K
Simplex trading	40.76K	0.00%	40.76K	$134.00K

Sold Out

Holder	Change
Fmr	-1.00
West branch capital	-25.00
Allworth financial lp	-200.00
Macquarie group	-1.11K
Redwood wealth management group	-1.40K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	99	19.28%	27,885,908	-0.82%	45	1.53%	54	22.73%	15	-37.50%
Jun 30, 2024	83	9.21%	28,117,599	22.50%	54	2.08%	44	-18.52%	24	500.00%
Mar 31, 2024	76	46.15%	22,952,291	161.33%	51	11.36%	54	200.00%	4	-63.64%
Dec 31, 2023	52	4.00%	8,782,945	13.39%	21	5.22%	18	-30.77%	11	-15.38%
Sep 30, 2023	50	6.38%	7,745,767	-19.36%	20	2.73%	26	-23.53%	13	116.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.29M	2.18%	-
iShares Russell 2000 ETF	1.23M	2.07%	-2.77K
Vanguard Institutional Extnd Mkt Idx Tr	782.88K	1.32%	-27.10K
HBM Healthcare Investments AG Ord	717.82K	1.21%	-
abrdn Healthcare Investors	626.64K	1.05%	-
Fidelity Small Cap Index	500.44K	0.84%	-12.49K
iShares Russell 2000 Value ETF	492.03K	0.83%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	287.79K	0.48%	-10.00K
abrdn Life Sciences Investors	286.41K	0.48%	-
Fidelity Extended Market Index	264.30K	0.44%	-9.84K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 28, 2023	Connealy Pamela Ann	CFO and COO	Buy	$14.96K
Sep 27, 2023	Wadhane Jitendra	Chief Accounting Officer	Buy	$4.67K
Sep 27, 2023	Connealy Pamela Ann	CFO and COO	Buy	$11.87K
Sep 25, 2023	Wadhane Jitendra	Chief Accounting Officer	Buy	$8.85K
Sep 25, 2023	Connealy Pamela Ann	CFO and COO	Buy	$20.04K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	7	5
2023 Q1	2	-

PYXS Ownership FAQ

Who Owns Pyxis Oncology?

Pyxis Oncology shareholders are primarily institutional investors at 45.93%, followed by 24.54% insiders and 29.53% retail investors. The average institutional ownership in Pyxis Oncology's industry, Biotech Stocks , is 44.70%, which Pyxis Oncology exceeds.

Who owns the most shares of Pyxis Oncology?

Pyxis Oncology’s largest shareholders are Deep track capital, lp (4.18M shares, 8.16%), Laurion capital management lp (3.86M shares, 7.53%), and Blackrock (2.79M shares, 5.43%). Together, they hold 21.12% of Pyxis Oncology’s total shares outstanding.

Does Blackrock own Pyxis Oncology?

Yes, BlackRock owns 5.43% of Pyxis Oncology, totaling 2.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.22M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 766.09% change.

Who is Pyxis Oncology’s biggest shareholder by percentage of total assets invested?

Stempoint capital lp is Pyxis Oncology’s biggest shareholder by percentage of total assets invested, with 1.17% of its assets in 1.2M Pyxis Oncology shares, valued at 3.98M$.

Who is the top mutual fund holder of Pyxis Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Pyxis Oncology shares, with 2.18% of its total shares outstanding invested in 1.29M Pyxis Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools